# MICAFUNGIN
> **NDA212125** · New Drug Application · Sponsor: TEVA PHARMS USA INC · Approved 2021-07-30
## Drug
- **FDA Application Number:** NDA212125
- **Application type:** New Drug Application
- **Brand name:** MICAFUNGIN
- **Generic name:** Micafungin Sodium
- **Active ingredients:** MICAFUNGIN SODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA INC
- **First approval:** 2021-07-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212125)
---
*MORVS · CC0 1.0*